We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

46 hedge funds and large institutions have $49.8M invested in InVivo Therapeutics Holdings Corp in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more call options, than puts

Call options by funds: $5.79M | Put options by funds: $2.57M

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

26% more capital invested

Capital invested by funds: $39.5M → $49.8M (+$10.4M)

21% more funds holding

Funds holding: 38 → 46 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
46
Holders Change
+8
Holders Change %
+21.05%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
13
Reduced
–
Closed
8
Calls
$5.79M
Puts
$2.57M
Net Calls
+$3.22M
Net Calls Change
+$1.68M

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$3.11M
2
BBA
Baker Bros. Advisors
New York
+$2.25M
3
Goldman Sachs
Goldman Sachs
New York
+$1.5M
4
BFA
BlackRock Fund Advisors
California
+$644K
5
BCM
Bridgeway Capital Management
Texas
+$536K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$737K
2
Group One Trading
Group One Trading
Illinois
-$322K
3
Stifel Financial
Stifel Financial
Missouri
-$268K
4
LCM
Landscape Capital Management
New Jersey
-$213K
5
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
-$151K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$6.85M +$429K +4 +8%
WF
2
Welch & Forbes
Massachusetts
$6.58M +$215K +2 +4%
BFA
3
BlackRock Fund Advisors
California
$5.74M +$644K +6 +16%
BIT
4
BlackRock Institutional Trust
California
$5.12M +$429K +4 +11%
SM
5
Sabby Management
Florida
$3.79M +$3.11M +29 New
State Street
6
State Street
Massachusetts
$2.79M +$322K +3 +17%
BBA
7
Baker Bros. Advisors
New York
$2.79M +$2.25M +21 New
Goldman Sachs
8
Goldman Sachs
New York
$2.44M +$1.5M +14 +280%
Northern Trust
9
Northern Trust
Illinois
$1.97M – – –
ICM
10
IMS Capital Management
Oregon
$1.89M +$107K +1 +8%
Morgan Stanley
11
Morgan Stanley
New York
$1.06M +$322K +3 +60%
BIM
12
BlackRock Investment Management
Delaware
$856K +$215K +2 +40%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$760K +$215K +2 +50%
BCM
14
Bridgeway Capital Management
Texas
$633K +$536K +5 New
TCIM
15
TIAA CREF Investment Management
New York
$608K – – –
EIM
16
Emerson Investment Management
Massachusetts
$518K – – –
California State Teachers Retirement System (CalSTRS)
17
California State Teachers Retirement System (CalSTRS)
California
$473K +$107K +1 +33%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$459K +$322K +3 +300%
LPL Financial
19
LPL Financial
California
$311K – – –
UBS Group
20
UBS Group
Switzerland
$294K – – –
TA
21
Teachers Advisors
New York
$269K – – –
Charles Schwab
22
Charles Schwab
California
$262K – – –
Deutsche Bank
23
Deutsche Bank
Germany
$255K +$215K +2 New
CDH
24
Charles D. Hyman
$224K +$215K +2 New
Renaissance Technologies
25
Renaissance Technologies
New York
$221K +$215K +2 New
1
2 3

NVIV Hedge Fund Activity: Q1 2016 in Review

46 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q1 2016, worth a combined $49.8M — up 26% from $39.5M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new NVIV positions and 8 closed out — a net gain of 8 holders — while 13 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $3.11M. The largest seller was Wellington Management Group, exiting entirely with an estimated $737K sold.

  • 46 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q1 2016, up from 38 in Q4 2015.
  • Funds reported $49.8M of InVivo Therapeutics Holdings Corp stock for Q1 2016, up 26% quarter-over-quarter.
  • 16 funds opened new InVivo Therapeutics Holdings Corp positions in Q1 2016 and 8 closed out, a net change of +8 holders.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q1 2016 was Sabby Management, an estimated $3.11M added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q1 2016 was Wellington Management Group, an estimated $737K sold.

Based on aggregated 13F filings for Q1 2016.